Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment.
about
Angiotensin-converting enzyme gene polymophism in adult primary focal segmental glomerulosclerosis.Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?Focal segmental glomerulosclerosis and parvovirus B19.Effects of pioglitazone and candesartan on renal fibrosis and the intrarenal plasmin cascade in spontaneously hypercholesterolemic rats.
P2860
Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Efficacy of losartan in patien ...... o immunosuppressive treatment.
@en
Efficacy of losartan in patien ...... o immunosuppressive treatment.
@nl
type
label
Efficacy of losartan in patien ...... o immunosuppressive treatment.
@en
Efficacy of losartan in patien ...... o immunosuppressive treatment.
@nl
prefLabel
Efficacy of losartan in patien ...... o immunosuppressive treatment.
@en
Efficacy of losartan in patien ...... o immunosuppressive treatment.
@nl
P2093
P2860
P1476
Efficacy of losartan in patien ...... o immunosuppressive treatment.
@en
P2093
Yurtkuran M
P2860
P304
P356
10.1046/J.1365-2796.2003.01071.X
P407
P577
2003-03-01T00:00:00Z